These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Storch EA, Merlo LJ, Bengtson M, Murphy TK, Lewis MH, Yang MC, Jacob ML, Larson M, Hirsh A, Fernandez M, Geffken GR, Goodman WK. Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647 [Abstract] [Full Text] [Related]
14. A controlled trial of clomipramine in childhood obsessive compulsive disorder. Flament MF, Rapoport JL, Kilts C. Psychopharmacol Bull; 1985 Jun; 21(1):150-2. PubMed ID: 3885292 [No Abstract] [Full Text] [Related]
15. Benefits of cognitive-behavioural therapy for children and youth with obsessive-compulsive disorder: re-examination of the evidence. O'Kearney R. Aust N Z J Psychiatry; 2007 Mar; 41(3):199-212. PubMed ID: 17464701 [Abstract] [Full Text] [Related]
16. Behavior therapy. Feldman J. Arch Gen Psychiatry; 1984 Jan; 41(1):107. PubMed ID: 6362608 [No Abstract] [Full Text] [Related]
17. Discontinuing obsessive-compulsive disorder medication with behavior therapy. Baer L, Ricciardi J, Keuthen N, Pettit AR, Buttolph ML, Otto M, Minichiello W, Jenike MA. Am J Psychiatry; 1994 Dec; 151(12):1842. PubMed ID: 7977900 [No Abstract] [Full Text] [Related]
18. Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: randomized compared with nonrandomized samples. Franklin ME, Abramowitz JS, Kozak MJ, Levitt JT, Foa EB. J Consult Clin Psychol; 2000 Aug; 68(4):594-602. PubMed ID: 10965635 [Abstract] [Full Text] [Related]